Study of Cabozantinib Plus TAS102 in mCRC as Salvage Therapy
收藏NIAID Data Ecosystem2026-03-12 收录
官方服务：
资源简介：
This is a phase I clinical trial assessing the safety and recommended phase II dose of cabozantinib in combination with trifluridine/tipiracil (TAS102) in patients with metastatic colorectal carcinoma (mCRC).
创建时间：
2021-07-15
